Multichain biotherapeutics: how to unlock their full potential
Sponsored by Lonza

Overcoming challenges in developing multichain biotherapeutics

Discover how
UK life science investments
News and Trends
October 1, 2025

Merck backs out of Britain: is the U.K. struggling to retain its life sciences sector? 

Merck’s decision to back out of its $1 billion expansion comes as U.K. investments in life sciences declines.
  • News and Trends
    October 1, 2025

    Asthma study suggests lung scarring may be reversible 

  • Best in Biotech
    September 30, 2025

    CRISPR technology’s next wave: Ten companies to watch in 2025 

  • News and Trends
    September 29, 2025

    First-ever approval for Barth Syndrome treatment: what does this mean for ultra-rare disease therapeutics? 

  • In Depth
    September 26, 2025

    Can biotechnology reduce animal testing in medicine?

Call for opportunities Call for opportunities
  • Latest Posts
  • Popular Posts
ADVERTISEMENT
Labiotech.eu

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Subscribe to our newsletter to get the latest biotech news!

By clicking this I agree to receive Labiotech's newsletter and understand that my personal data will be processed according to the Privacy Policy.*